Hans Peter Hasler is a senior executive and top-level advisor to the life-sciences industry. He has an international track record and in-depth operational, commercial, and general management expertise. During his career, Mr. Hasler has managed the growth of leading players in the pharmaceutical industry and has successfully launched several blockbuster drugs.
Mr. Hasler is Owner and Managing Director at HPH Management GmbH. HPH Management is consulting for Pharmaceutical and Biotechnological companies with focus on strategy, merger and acquisitions, licensing and marketing.
He was the Chief Executive Officer of Vicarius Pharma AG, a privately held European Bio-Pharma company until 2020. His prior experiences include Elan Corporation, Dublin, where he was Chief Operating Officer, and Biogen Inc., Boston, where his positions included Chief Operating Officer, and EVP, Head of Global Neurology and International.
Previously, Mr. Hasler was at Wyeth Pharmaceuticals, Radnor/PA, as Senior Vice President, Chief Marketing Officer and beforehand Managing Director of Wyeth Group Germany, Münster.
Hans Peter Hasler is Chairman of the Board of HBM Healthcare Investments AG in Switzerland (SIX), Chairman of the Board of Shield Therapeutics, London (AIM), and a Director of Minerva Neurosciences in Boston (Nasdaq) and Gain Therapeutics, Bethesda (Nasdaq). He holds a Federal Swiss Commercial Diploma and a Marketing Manager Certificate from the Swiss Institute of Business Economy SIB, Zurich.
Global Life Sciences Advisor, Switzerland
Chief Executive Officer, Vicarius Pharma, Switzerland
Chief Operating Officer, Elan Pharmaceuticals, Ireland/Switzerland
Chief Operating Officer, Biogen, USA
Head of Global Commercial Operations, Biogen, USA
Chief Marketing Officer, Wyeth, USA
Managing Director, Wyeth, Germany
General Manager, Wyeth, Switzerland/Austria/CEE
German, English, French
Chairman of the Board, HBM Healthcare Investments, Switzerland
Chairman of the Board, Shield Therapeutics plc, London
Director of the Board, Minerva Neuroscience Inc., Boston